Table 1. Association between Romo1 and clinicopathologic parameters.
No. of patients (%) | Average score of Romo1 | P value | |
---|---|---|---|
All | 208(100) | 13.6 | |
Gender | 0.581 | ||
Female | 93(45) | 13.9 | |
Male | 115(55) | 13.4 | |
Age | 0.845 | ||
<70 | 171(82) | 13.6 | |
≥70 | 37(18) | 13.9 | |
Stage | 0.869 | ||
I | 28(13) | 13.7 | |
II | 86(41) | 13.2 | |
III | 76(37) | 13.8 | |
IV | 18(9) | 14.9 | |
N stage | 0.547 | ||
N0 | 118(57) | 13.4 | |
≥N1 | 90(43) | 14.0 | |
LNR | 0.025 | ||
<0.1 | 151(73) | 12.9 | |
≥0.1 | 57(27) | 15.7 | |
T stage | 0.644 | ||
T1,T2 | 35(17) | 14.5 | |
T3,T4 | 173(83) | 13.5 | |
Lymphatic invasion | 0.043 | ||
Negative | 87(42) | 12.2 | |
Positive | 121(58) | 14.7 | |
Vascular invasion | 0.979 | ||
Negative | 132(63) | 13.4 | |
Positive | 76(37) | 13.9 | |
Tumor differentiation | 0.836 | ||
Well | 85(41) | 13.4 | |
Mod-poor | 123(59) | 13.8 |
N, lymph node; LNR, lymph node ratio; T, tumor